Page last updated: 2024-10-26

etanidazole and Laryngeal Neoplasms

etanidazole has been researched along with Laryngeal Neoplasms in 1 studies

Etanidazole: A nitroimidazole that sensitizes hypoxic tumor cells that are normally resistant to radiation therapy.
etanidazole : A monocarboxylic acid amide obtained by formal condensation of the carboxy group of (2-nitro-1H-imidazol-1-yl)acetic acid with the amino group of ethanolamine. Used as a radiosensitising agent for hypoxic tumour cells.

Laryngeal Neoplasms: Cancers or tumors of the LARYNX or any of its parts: the GLOTTIS; EPIGLOTTIS; LARYNGEAL CARTILAGES; LARYNGEAL MUSCLES; and VOCAL CORDS.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Evans, SM1
Du, KL1
Chalian, AA1
Mick, R1
Zhang, PJ1
Hahn, SM1
Quon, H1
Lustig, R1
Weinstein, GS1
Koch, CJ1

Other Studies

1 other study available for etanidazole and Laryngeal Neoplasms

ArticleYear
Patterns and levels of hypoxia in head and neck squamous cell carcinomas and their relationship to patient outcome.
    International journal of radiation oncology, biology, physics, 2007, Nov-15, Volume: 69, Issue:4

    Topics: Aged; Carcinoma, Squamous Cell; Cell Hypoxia; Etanidazole; Female; Fluorescent Antibody Technique; H

2007